Taking all this evidence together, in conjunction with the results of the present study, we believe that the isolated detection of RRM1 or ERCC1 expression in PDA has little clinical relevance and deserves further investigation before formal recommendation regarding its use in clinical practice can be made. This evidence concerns the gene RRM1 and Patent ductus arteriosus.